{"id":40596,"date":"2024-01-03T16:15:11","date_gmt":"2024-01-03T16:15:11","guid":{"rendered":"https:\/\/www.elza-institute.com\/?p=40596"},"modified":"2024-07-15T09:14:23","modified_gmt":"2024-07-15T09:14:23","slug":"corneal-cross-linking-whats-new-in-2023","status":"publish","type":"post","link":"https:\/\/www.elza-institute.com\/pt\/corneal-cross-linking-whats-new-in-2023\/","title":{"rendered":"Cross-Linking da c\u00f3rnea: O que h\u00e1 de novo em 2023?"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

ACTUALIZA\u00c7\u00c3O: Este artigo foi designado como um dos O oftalmologista<\/i>Os 10 melhores artigos de 2023!<\/b><\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\"A oftalmologia est\u00e1 em constante evolu\u00e7\u00e3o e esfor\u00e7a-se por ultrapassar os limites\" \u00e9 o que afirma o Diretor M\u00e9dico da ELZA, Prof. Farhad Hafezi<\/a> disse aoO oftalmologista<\/em>' no artigo \"Cross-Linking da c\u00f3rnea: O que h\u00e1 de novo em 2023?<\/a>\" publicado na semana passada.<\/p>\n

No artigo, revela como a equipa foi al\u00e9m da utiliza\u00e7\u00e3o do reticulado da c\u00f3rnea (CXL) para tratar a progress\u00e3o da doen\u00e7a, concentrando-se no desenvolvimento de protocolos de tratamento mais r\u00e1pidos e mais eficientes.<\/p>\n

<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t

\n\t\t\t\t\"Outro desenvolvimento fundamental, o PACE, combina a reticula\u00e7\u00e3o com um PTK guiado por um mapa epitelial para melhorar a acuidade visual.\"\t\t\t<\/p>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\tFarhad Hafezi<\/cite>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/path><\/svg>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tTweet<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Por exemplo, o Prof. Hafezi n\u00e3o s\u00f3 mostra como a equipa do Instituto ELZA inovou para desenvolver o CXL para al\u00e9m do m\u00e9todo do protocolo de Dresden, que existe h\u00e1 d\u00e9cadas, para a reticula\u00e7\u00e3o da c\u00f3rnea, acelerando o processo sem perder a sua efic\u00e1cia. H\u00e1 uma d\u00e9cada, o seu grupo de investiga\u00e7\u00e3o descobriu que o fornecimento r\u00e1pido da flu\u00eancia do protocolo de Dresden esgotaria o oxig\u00e9nio - um componente essencial da rea\u00e7\u00e3o fotoqu\u00edmica UV-riboflavina. Atualmente, no entanto, os cirurgi\u00f5es e investigadores do ELZA desenvolveram um novo protocolo que n\u00e3o s\u00f3 \u00e9 tr\u00eas vezes mais r\u00e1pido do que o Dresden, mas igualmente forte, e t\u00eam\u00a0publicou dados laboratoriais iniciais promissores<\/a>e, em seguida, um seguimento cl\u00ednico de 2 anos para validar estes resultados.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u00a0<\/p>

O Prof. Hafezi aprofundou os \u00faltimos avan\u00e7os no tratamento do ceratocone, desenvolvidos em coordena\u00e7\u00e3o com<\/span>\u00a0<\/span>Prof. Shady Awwad<\/a>\u00a0<\/span>da Universidade Americana de Beirute, denominado Phototherapeutic Keratectomy-Assisted Customized Epi-on corneal cross-linking, ou mais simplesmente, PACE.<\/span>\u00a0<\/span>Reticula\u00e7\u00e3o personalizada PACE<\/a>\u00a0<\/span>combina o cross-linking corneano epi-on com um PTK guiado por um mapa epitelial para melhorar a acuidade visual - um desenvolvimento que j\u00e1 est\u00e1 a mudar o que \u00e9 poss\u00edvel em termos de melhoria dos resultados visuais de doentes com ectasias corneanas como o ceratocone.<\/span><\/p>

\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Reticula\u00e7\u00e3o\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Antes\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Al\u00e9m disso, o Prof. Hafezi tamb\u00e9m discutiu os desafios do tratamento de c\u00f3rneas ultrafinas, oferecendo uma nova solu\u00e7\u00e3o atrav\u00e9s da\u00a0abordagem de reticula\u00e7\u00e3o individualizada sub400<\/a>.<\/p>

Com estes avan\u00e7os inovadores, o Prof. Hafezi n\u00e3o s\u00f3 destaca o progresso que o ELZA e os seus colegas fizeram no campo em geral, como tamb\u00e9m oferece uma vis\u00e3o otimista do futuro. \u00c0 medida que a sua investiga\u00e7\u00e3o continua, aproxima-nos mais um passo para proporcionar resultados ainda melhores aos doentes que sofrem de ceratocone.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

O artigo do Oftalmologista \"CXL: What's New in 2023?\" (O que h\u00e1 de novo em 2023?) explora os avan\u00e7os no crosslinking de colag\u00e9nio da c\u00f3rnea para o tratamento do ceratocone. Farhad Hafezi, da ELZA, discute como o CXL avan\u00e7ou at\u00e9 ao estado atual da arte e destaca novos avan\u00e7os como o sub400 e o PACE.<\/p>","protected":false},"author":4,"featured_media":40603,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[214,1,96,467],"tags":[],"class_list":["post-40596","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-farhad-hafezi","category-general-news","category-popular-press","category-top-10"],"acf":[],"yoast_head":"\nCorneal Cross-Linking: What's New in 2023?<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elza-institute.com\/pt\/corneal-cross-linking-whats-new-in-2023\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Corneal Cross-Linking: What's New in 2023?\" \/>\n<meta property=\"og:description\" content=\"The Ophthalmologist's "CXL: What's New in 2023?" article explores advancements in corneal collagen crosslinking for treating keratoconus. ELZA's Farhad Hafezi discusses how CXL has advanced to the current state of the art, and highlights new breakthroughs like sub400 and PACE.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elza-institute.com\/pt\/corneal-cross-linking-whats-new-in-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"The ELZA Institute\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ELZA.Institute\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-03T16:15:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-15T09:14:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/07\/CXL-Whats-New-in-2023-.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mark Hillen\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark Hillen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/\"},\"author\":{\"name\":\"Mark Hillen\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15\"},\"headline\":\"Corneal Cross-Linking: What’s New in 2023?\",\"datePublished\":\"2024-01-03T16:15:11+00:00\",\"dateModified\":\"2024-07-15T09:14:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/\"},\"wordCount\":357,\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/07\/CXL-Whats-New-in-2023-.jpg\",\"articleSection\":[\"Farhad Hafezi\",\"News\",\"Popular press\",\"Top 10\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/\",\"url\":\"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/\",\"name\":\"Corneal Cross-Linking: What's New in 2023?\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/07\/CXL-Whats-New-in-2023-.jpg\",\"datePublished\":\"2024-01-03T16:15:11+00:00\",\"dateModified\":\"2024-07-15T09:14:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#primaryimage\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/07\/CXL-Whats-New-in-2023-.jpg\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/07\/CXL-Whats-New-in-2023-.jpg\",\"width\":1200,\"height\":600,\"caption\":\"CXL: What's New in 2023?\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.elza-institute.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farhad Hafezi\",\"item\":\"https:\/\/www.elza-institute.com\/farhad-hafezi\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Corneal Cross-Linking: What’s New in 2023?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.elza-institute.com\/#website\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"name\":\"The ELZA Institute\",\"description\":\"Swiss EyeCare at its finest\",\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.elza-institute.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.elza-institute.com\/#organization\",\"name\":\"The ELZA Institute\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"width\":1181,\"height\":453,\"caption\":\"The ELZA Institute\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ELZA.Institute\/\",\"https:\/\/x.com\/ELZA_Institute\",\"https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15\",\"name\":\"Mark Hillen\",\"url\":\"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cross-Linking da c\u00f3rnea: O que h\u00e1 de novo em 2023?","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elza-institute.com\/pt\/corneal-cross-linking-whats-new-in-2023\/","og_locale":"pt_PT","og_type":"article","og_title":"Corneal Cross-Linking: What's New in 2023?","og_description":"The Ophthalmologist's \"CXL: What's New in 2023?\" article explores advancements in corneal collagen crosslinking for treating keratoconus. ELZA's Farhad Hafezi discusses how CXL has advanced to the current state of the art, and highlights new breakthroughs like sub400 and PACE.","og_url":"https:\/\/www.elza-institute.com\/pt\/corneal-cross-linking-whats-new-in-2023\/","og_site_name":"The ELZA Institute","article_publisher":"https:\/\/www.facebook.com\/ELZA.Institute\/","article_published_time":"2024-01-03T16:15:11+00:00","article_modified_time":"2024-07-15T09:14:23+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/07\/CXL-Whats-New-in-2023-.jpg","type":"image\/jpeg"}],"author":"Mark Hillen","twitter_misc":{"Escrito por":"Mark Hillen","Tempo estimado de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#article","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/"},"author":{"name":"Mark Hillen","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15"},"headline":"Corneal Cross-Linking: What’s New in 2023?","datePublished":"2024-01-03T16:15:11+00:00","dateModified":"2024-07-15T09:14:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/"},"wordCount":357,"publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"image":{"@id":"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/07\/CXL-Whats-New-in-2023-.jpg","articleSection":["Farhad Hafezi","News","Popular press","Top 10"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/","url":"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/","name":"Cross-Linking da c\u00f3rnea: O que h\u00e1 de novo em 2023?","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/07\/CXL-Whats-New-in-2023-.jpg","datePublished":"2024-01-03T16:15:11+00:00","dateModified":"2024-07-15T09:14:23+00:00","breadcrumb":{"@id":"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#primaryimage","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/07\/CXL-Whats-New-in-2023-.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/07\/CXL-Whats-New-in-2023-.jpg","width":1200,"height":600,"caption":"CXL: What's New in 2023?"},{"@type":"BreadcrumbList","@id":"https:\/\/www.elza-institute.com\/corneal-cross-linking-whats-new-in-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elza-institute.com\/"},{"@type":"ListItem","position":2,"name":"Farhad Hafezi","item":"https:\/\/www.elza-institute.com\/farhad-hafezi\/"},{"@type":"ListItem","position":3,"name":"Corneal Cross-Linking: What’s New in 2023?"}]},{"@type":"WebSite","@id":"https:\/\/www.elza-institute.com\/#website","url":"https:\/\/www.elza-institute.com\/","name":"O Instituto ELZA","description":"Swiss EyeCare no seu melhor","publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elza-institute.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/www.elza-institute.com\/#organization","name":"O Instituto ELZA","url":"https:\/\/www.elza-institute.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","width":1181,"height":453,"caption":"The ELZA Institute"},"image":{"@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ELZA.Institute\/","https:\/\/x.com\/ELZA_Institute","https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home"]},{"@type":"Person","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15","name":"Mark Hillen","url":"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/40596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/comments?post=40596"}],"version-history":[{"count":0,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/40596\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media\/40603"}],"wp:attachment":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media?parent=40596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/categories?post=40596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/tags?post=40596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}